Skip to content

Tongli Pharmaceuticals (USA), Inc.

company.status.inactive

CIK 1052284fmd_1YKTZRJH8BH39RQ27186XMV3RTManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Dec 31, 2013, 15 periods

Income Statement · Annual · Millions · USD
Line itemFY2011FY2012FY2013
Cost of revenue8105
Gross profit766
Total operating expenses123
Operating income632
Interest expense000
Other non-operating income (expense)(0)(0)(0)
Income before taxes632
Income tax expense211
Net income from continuing operations421
Net income421